SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech fireworks
An SI Board Since October 2001
Posts SubjectMarks Bans
7424 222 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
5824<Sigh> OK, if you're right, I'll give you a buck. If you're The Dodgy Ticker-12/6/2011
5823I’ve seen this movie. Many times :-)DewDiligence_on_SI-12/6/2011
5822Prediction: The 39% figure reported in today’s PR will not stand up to scrutinyThe Dodgy Ticker-12/6/2011
5821Prediction: The 39% figure reported in today’s PR will not stand up to scrutiny,DewDiligence_on_SI-12/6/2011
5820:-)The Dodgy Ticker-12/6/2011
5819Still up 27% with an hour to trade, 6.3 million shares under bridge. Go Bob!scaram(o)uche112/6/2011
5818PPHM is up 39% in pre-market trading.<g> It said that results show combinJibacoa-12/6/2011
5817Affymax Inc. (AFFY) surged the most in 16 months after U.S. regulators said the tnsaf-12/5/2011
5816ANTH was up 19.17% at its intraday H and is still up 16.99% on volume of >1Jibacoa-12/2/2011
5815TSPT, Now up 21.66% to 8.48 on news from yesterday.(click back) Stock is on itmanny t-12/1/2011
5814 TSPT news, Transcept Pharmaceuticals Announces Purdue's Exmanny t-11/30/2011
5813Rick, yes, there were a few that met Nigel's requirement and closed up 15%. Jibacoa-11/30/2011
5812pgnx, sgmo, omer, infi..... many others, I presume.scaram(o)uche-11/30/2011
5811Thanks for the pointer. A whole bunch of good biotechs up more than the general scaram(o)uche-11/30/2011
5810Progenics (PGNX) up 17% on average volume. Don't see news. Cheers, Tucktuck-11/30/2011
5809Inhibitex (INHX) finished up 19% on the coattails of the VRUS buyout. Cheers, tuck-11/21/2011
5808<i>>If the VRUS drug is rejected, very bad indeed.<</i> VRUDewDiligence_on_SI-11/21/2011
5807If this puts GILD ahead of the pack in HCV drugs, it should be worth the cost. IChris08-11/21/2011
5806VRUS +84% as GILD goes shopping Oh, and GILD -11% Along with the rest of the mtnsaf-11/21/2011
5805ONTY, Was up over 15% to 7.39 high,now 7.25. Incredible price upgrade to 31 fmanny t-11/16/2011
5804OPXA, Up 34% to 1.38 on FDA news, OPXA-Opexa’s Tovaxin® for the Treatmentmanny t-11/8/2011
5803ACOR +17% at Friday's high; closed +12% – favorable earnings report and AMPYtnsaf-11/5/2011
5802AMAG opened with a good UG and is still up > 18% after his CEO resigned and Jibacoa-11/4/2011
5801INHX has been up 135.10% and is still up 118% with volume of 21M about 42x its AJibacoa-11/4/2011
5800INHX up 125% in pre-market trading after reporting 3rdQ results and "RecenJibacoa-11/4/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News